Are GLP-1 drugs somehow able to boost fertility
Sikirica M, Martin A, Wood R, et al
" Foundayo marks a significant advancement in obesity treatment by providing patients with a convenient daily pill option instead of weekly injections ." FDA Approval Statement, 2026 What Makes Orforglipron Different From Earlier Pills Like other GLP-1 drugs, Foundayo mimics the hormone that controls appetite, digestion, and insulin
Whilst this has not been conclusively demonstrated in humans, caution is advised in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Key highlights: Once-daily oral administration No food or water restrictions No injections required ~12% mean weight loss in Phase 3 trials Improvements in cardiometabolic risk markers Indication: Approved for adults with obesity, or overweight individuals with weight-related comorbidities, alongside reduced-calorie diet and increased physical activity
You cant start turning off ways of getting access to medications that are incredibly helpful for people without providing us alternative strategies.